Paragon 28’s Financial Turnaround: Exceeding Expectations and Raising Price Targets
Analyst Michael Matson of Needham maintained a Buy rating on Paragon 28 (FNA – Research Report), with a price target of $13.00. Michael ...
Buy Rating on Paragon 28: Strong Financial Performance, Strategic Initiatives, and Niche ...
Paragon 28 (FNA – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst David Turkaly ...
Dallas Innovates1 小时
Patented: Verily Life Sciences’ Eye-Mountable Therapeutic Devices and More North Texas ...
Abstract: Systems, eye-mountable devices, and methods that facilitate chronotherapeutic treatment of primary open-angle ...
Taiwan News13 小时
Artificial Tendons and Ligaments Market Product Types, Applications, and Materials Forecast ...
Government initiatives and funding for orthopedic research further contribute to market dynamics ... Global Artificial Tendons and Ligaments Market is divided into Knee Injuries, Shoulder Injuries, ...